Calidi Biotherapeutics, Inc.
CLDI· NYSE
CLDICalidi Biotherapeutics, Inc.
Filed May 14, 2025 · 10-Q · 44 days after period end · 0001641172-25-010317
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$4.99M | -$7.23M | -$6.46M | -$7.74M |
| EPS Diluted | -$2.21 | -$2.03 | -$0.75 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Calidi Biotherapeutics, Inc. · CIK 1855485 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 14, 2025 · 44 d after period end
